No connection

Search Results

ARES

NEUTRAL
$155.89 Live
Ares Management Corporation · NYSE
Target $194.44 (+24.7%)
$110.63 52W Range $200.49

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$51.07B
P/E
68.07
ROE
17.1%
Profit margin
12.1%
Debt/Equity
1.47
Dividend yield
2.77%

AI Analysis

AI-powered fundamental assessment

Confidence
68%
ARES exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating solid profitability and operational efficiency. However, the stock trades at a significant premium to both Graham's defensive value ($26.55) and intrinsic value ($67.56), currently priced at $155.89, reflecting high growth expectations. While revenue and earnings growth are robust—46.7% and 108.8% YoY respectively—the elevated valuation metrics (P/E of 68.07, P/B of 11.40) and bearish insider activity raise sustainability concerns. The technical trend is bearish, and the dividend payout ratio of 181% signals potential instability in income sustainability.

Key Strengths

Strong Piotroski F-Score of 7/9 indicates high financial health and consistent profitability
Exceptional year-over-year revenue (46.7%) and earnings growth (108.8%)
High return on equity (17.09%) outperforms sector average despite negative peer ROE
Low debt/equity relative to sector average (1.47 vs 1.92)
Analyst consensus recommendation is 'buy' with a $194.44 target price implying 24.7% upside

Key Risks

Extremely high P/E ratio (68.07) vs sector average (21.16) suggests overvaluation
Dividend payout ratio of 181.01% is unsustainable long-term
Insider selling of $562.11M in the last 6 months signals lack of confidence from executives
Current and quick ratios below 0.5 indicate potential short-term liquidity pressure
Technical trend is bearish with 1-year price return of -18.2% and recent downward momentum
AI Fair Value Estimate
Based on comprehensive analysis
$78.5
-49.6% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
58
Moderate
Value
38
Future
82
Past
66
Health
74
Dividend
32
AI Verdict
Moderate potential with significant valuation and sentiment risks
Key drivers: High Piotroski score and strong growth, Rich valuation multiples, Bearish insider and technical signals, Unsustainable dividend payout, Analyst optimism
Confidence
72%
Value
38/100

Ref P/E, PEG, Graham Number

Positives
  • Intrinsic value estimate of $67.56 suggests some underlying value
Watchpoints
  • Current price ($155.89) is 133% above Graham Number ($26.55)
  • P/E of 68.07 is triple the sector average
  • Price/Book of 11.40 indicates extreme premium to book value
Future
82/100

Ref Growth rates

Positives
  • Revenue growth of 46.7% YoY exceeds sector average
  • Earnings growth of 108.8% YoY shows strong momentum
  • Q/Q earnings growth of 143.9% indicates accelerating profitability
Watchpoints
No urgent risks highlighted.
Past
66/100

Ref Historical trends

Positives
  • 5-year price return of +300.6% shows strong historical performance
  • Long-term earnings progression is upward despite volatility
Watchpoints
  • 1-year return of -18.2% and bearish technical trend indicate recent underperformance
  • Earnings surprises are inconsistent (2 out of last 4 beats)
Health
74/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 7/9 indicates strong financial health
  • ROE of 17.09% is healthy and stable
  • Debt/Equity of 1.47 is below sector average
Watchpoints
  • Current ratio (0.49) and quick ratio (0.43) suggest short-term liquidity risk
  • Altman Z-Score not available, limiting distress risk assessment
Dividend
32/100

Ref Yield, Payout

Positives
  • Dividend yield of 2.77% is above sector average
Watchpoints
  • Payout ratio of 181.01% is unsustainable
  • Dividend strength score of 20/100 indicates weak reliability

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$155.89
Analyst Target
$194.44
Upside/Downside
+24.7%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ARES and closest competitors.

Updated 2026-01-23
ARE
Ares Management Corporation
Primary
5Y
+300.6%
3Y
+116.1%
1Y
-18.2%
6M
-15.2%
1M
-7.8%
1W
-8.1%
BSB
Banco Santander (Brasil) S.A.
Peer
5Y
+32.0%
3Y
+44.7%
1Y
+66.4%
6M
+42.2%
1M
+10.6%
1W
+10.4%
NDA
Nasdaq, Inc.
Peer
5Y
+70.7%
3Y
+59.2%
1Y
+20.3%
6M
-0.6%
1M
-0.0%
1W
-2.5%
ALL
The Allstate Corporation
Peer
5Y
+98.8%
3Y
+91.6%
1Y
+0.5%
6M
-2.0%
1M
-3.9%
1W
-0.1%
COI
Coinbase Global, Inc.
Peer
5Y
-46.8%
3Y
+158.4%
1Y
+1.4%
6M
-48.3%
1M
-5.7%
1W
-3.5%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
68.07
Forward P/E
23.77
PEG Ratio
N/A
P/B Ratio
11.4
P/S Ratio
9.54
EV/Revenue
9.56
EV/EBITDA
38.71
Market Cap
$51.07B

Profitability

Profit margins and return metrics

Profit Margin 12.14%
Operating Margin 24.1%
Gross Margin 37.19%
ROE 17.09%
ROA 2.68%

Growth

Revenue and earnings growth rates

Revenue Growth +46.7%
Earnings Growth +108.8%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +143.9%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
1.47
Moderate
Current Ratio
0.49
Weak
Quick Ratio
0.43
Poor
Cash/Share
$6.81

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-05
$N/A
2025-11-03
$1.19
+4.7% surprise
2025-08-01
$1.03
-5.8% surprise
2025-05-05
$1.09
+15.9% surprise

Financial Services Sector Comparison

Comparing ARES against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
P/E Ratio
68.07
This Stock
vs
36.01
Sector Avg
+89.0% (Expensive)
Return on Equity (ROE)
17.09%
This Stock
vs
-0.73%
Sector Avg
-2432.0% (Below Avg)
Profit Margin
12.14%
This Stock
vs
91.62%
Sector Avg
-86.7% (Weaker)
Debt to Equity
1.47
This Stock
vs
1.36
Sector Avg
+8.5% (Higher)
Revenue Growth
46.7%
This Stock
vs
35.27%
Sector Avg
+32.4% (Fast Growth)
Current Ratio
0.49
This Stock
vs
3.18
Sector Avg
-84.5% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

SAGATI AGHILI NASEEM
General Counsel
Stock Award
2026-01-20
2,712 shares
PHILLIPS JARROD
Chief Financial Officer
Stock Award
2026-01-20
2,712 shares
KAPLAN DAVID B
Officer and Director
Gift
2025-12-16
40,000 shares
ROSENTHAL BENNETT
Officer and Director
Gift
2025-12-16
15,000 shares
SAGATI AGHILI NASEEM
General Counsel
Gift
2025-12-09
500 shares
AROUGHETI MICHAEL J
Chief Executive Officer
Sell
2025-12-01
290,997 shares · $45,274,799
AROUGHETI MICHAEL J
Chief Executive Officer
Sell
2025-11-25
299,003 shares · $45,380,330
AROUGHETI MICHAEL J
Chief Executive Officer
Stock Award
2025-11-14
590,000 shares
SAGATI AGHILI NASEEM
General Counsel
Sell
2025-10-01
21,000 shares · $3,275,370
RESSLER ANTONY P
Officer, Director and Beneficial Owner
Sell
2025-09-10
128,837 shares · $22,971,970
SAGATI AGHILI NASEEM
General Counsel
Sell
2025-09-10
21,000 shares · $3,746,321
RESSLER ANTONY P
Officer, Director and Beneficial Owner
Sell
2025-09-09
271,741 shares · $47,742,182
RESSLER ANTONY P
Officer, Director and Beneficial Owner
Sell
2025-09-05
464,939 shares · $82,605,017
RESSLER ANTONY P
Officer, Director and Beneficial Owner
Sell
2025-09-02
278,961 shares · $49,896,005
RESSLER ANTONY P
Officer, Director and Beneficial Owner
Sell
2025-08-28
280,060 shares · $50,528,376
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
16 analysts
TD Cowen
2026-01-14
Maintains
Buy Buy
UBS
2026-01-13
Maintains
Neutral Neutral
Barclays
2026-01-09
Maintains
Overweight Overweight
Barclays
2025-12-12
Maintains
Overweight Overweight
TD Cowen
2025-11-04
Maintains
Buy Buy
Keefe, Bruyette & Woods
2025-11-04
Maintains
Outperform Outperform
Morgan Stanley
2025-10-21
Maintains
Equal-Weight Equal-Weight
Oppenheimer
2025-10-14
up
Perform Outperform
Barclays
2025-10-08
Maintains
Overweight Overweight
B of A Securities
2025-10-03
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning ARES from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile